Sign in
QSAM Stock Price, Chart, Stats & News
QSAM Biosciences, Inc.
Save
QSAM Biosciences, Inc. (QSAM) does not currently pay a dividend.
18,443
Market cap
–
Current P/E
–
Forward P/E
QSAM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -257.62% |
ROE | 1617.91% |
D/E | 0.01x |
Interest coverage ratio | -74.83x |
QSAM valuation
P/E | – |
P/S | – |
P/B | 43.58x |
P/CF | -10.29x |
P/FCF | -0.01x |
P/OCF | -10.29x |
PEG | -0.07x |
EV multiple | 0.00x |
About
Based in Austin, Texas, QSAM Biosciences, Inc. is dedicated to advancing nuclear medicine for cancer and related illnesses. A key component of their pipeline is CycloSam (Samarium-153 DOTMP), a radiopharmaceutical currently in clinical development that specifically targets bone. The company holds a licensing agreement with IGL Pharma, Inc.
Similar securities
Based on sector and market capitalization
Report issue